Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 4, 1999
Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brainM Kathmann, U Bauer, E Schlicker, et al.
Fundamental & Clinical Pharmacology|January 1, 1994
Modulation of neurotransmitter release via histamine H3 heteroreceptorsE Schlicker, B Malinowska, M Kathmann, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|April 29, 2008
Identification of a presynaptic cannabinoid CB1 receptor in the guinea-pig atrium and sequencing of the guinea-pig CB1 receptorC M Kurz, C Gottschalk, E Schlicker, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 29, 2000
Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptorsM Nakazi, U Bauer, T Nickel, et al.
British Journal of Pharmacology|June 16, 1999
Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitroS Werthwein, U Bauer, M Nakazi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 2005
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aortaT Schultheiss, K Flau, M Kathmann, et al.
British Journal of Pharmacology|August 1, 1994
Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor modelsE Schlicker, M Kathmann, S Reidemeister, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 1999
The stereoselective kappa-opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptorU Bauer, M Nakazi, M Kathmann, et al.
British Journal of Pharmacology|December 6, 2002
Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptorsK Flau, A Redmer, S Liedtke, et al.
Pageof 17